1.19
price down icon4.03%   -0.05
after-market Handel nachbörslich: 1.19
loading

Finanzdaten der Dermata Therapeutics Inc-Aktie (DRMA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-07-01 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
1.7607
- 2.3398 3.2003 3.2257
Operating Income/Loss
-1.7607
- -2.3398 -3.2003 -3.2257
Income/Loss From Continuing Operations Before Tax
0.54%
-1.692
-1.7011 -2.3036 -3.1509 -3.1732
Income/Loss From Continuing Operations After Tax
0.54%
-1.692
-1.7011 -2.3036 -3.1509 -3.1732
Net Income/Loss
0.54%
-1.692
-1.7011 -2.3036 -3.1509 -3.1732
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1.0265
- 5.1547 - -
Diluted Average Shares
1.0265
- 5.1547 - -
Basic Earnings Per Share
-1.65
- -0.45 - -
Diluted Earnings Per Share
-1.65
- -0.45 - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):